Protein matrix materials, devices and methods of making and using thereof
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/00
A61K-009/70
A61K-038/16
A61K-047/42
A61L-027/38
A61L-027/50
A61L-027/54
A61L-027/58
A61L-031/16
A61L-031/10
A61L-027/22
출원번호
US-0700896
(2010-02-05)
등록번호
US-8871267
(2014-10-28)
발명자
/ 주소
Masters, David B.
출원인 / 주소
Gel-Del Technologies, Inc.
대리인 / 주소
Patterson Thuente Pedersen, P.A.
인용정보
피인용 횟수 :
2인용 특허 :
115
초록▼
The present invention relates to protein matrix materials and devices and the methods of making and using protein matrix materials and devices. More specifically the present invention relates to protein matrix materials and devices that may be utilized for various medical applications including, but
The present invention relates to protein matrix materials and devices and the methods of making and using protein matrix materials and devices. More specifically the present invention relates to protein matrix materials and devices that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, encapsulated or coated stent devices, vessels, tubular grafts, vascular grafts, wound healing devices including protein matrix suture material and meshes, skin/bone/tissue grafts, biocompatible electricity conducting matrices, clear protein matrices, protein matrix adhesion prevention barriers, cell scaffolding and other biocompatible protein matrix devices. Furthermore, the present invention relates to protein matrix materials and devices made by forming a film comprising one or more biodegradable protein materials, one or more biocompatible solvents and optionally one or more pharmacologically active agents. The film is then partially dried, rolled or otherwise shaped, and then compressed to form the desired protein matrix device.
대표청구항▼
1. A tissue graft comprising one or more biocompatible protein materials, combined with one or more biocompatible solvents, wherein the protein material(s) and biocompatible solvent(s) are formed into a cohesive solid body having a solvent content of about 20% to 80% prior to compression and not hav
1. A tissue graft comprising one or more biocompatible protein materials, combined with one or more biocompatible solvents, wherein the protein material(s) and biocompatible solvent(s) are formed into a cohesive solid body having a solvent content of about 20% to 80% prior to compression and not having the characteristics of cracking, shattering, breaking or being crosslinked so as to inhibit the cohesive solid body from remaining cohesive unto itself when being formed and the cohesive solid body is compressed at a pressure of about 100 psi to 100,000 psi to remove bulk biocompatible solvent and generate additional intermolecular and intramolecular forces between one or more of the protein material(s) and solvent(s) to form the tissue graft having a solvent content of about 10% to 60%, and wherein the tissue graft provides a scaffold for enhancing cellular remodeling by host tissue. 2. The tissue graft of claim 1 wherein the biocompatible proteins may be natural, synthetic or genetically engineered. 3. The tissue graft of claim 2 wherein the biocompatible proteins are natural proteins selected from the group consisting of elastin, collagen, albumin, keratin, fibronectin, silk, silk fibroin, actin, myosin, fibrinogen, thrombin, aprotinin and antithrombin III. 4. The tissue graft of claim 2 wherein the biocompatible proteins are genetically engineered proteins including blocks of peptide sequences comprising groups of amino acids, collagen-heparin and collagen-chondroiten. 5. The tissue graft of claim 1 wherein the one or more biocompatible solvents are selected from the group consisting of water, dimethyl sulfoxide (DMSO), biocompatible alcohols, biocompatible acids, oils and biocompatible glycols. 6. The tissue graft of claim 1 further comprising one or more pharmacologically active agents, cells or a combination thereof. 7. The tissue graft of claim 6 wherein the one or more pharmacologically active agents are selected from the group consisting of analgesics, anesthetics, antipsychotic agents, steroids, antisteroids, corticosteroids, antiglacoma agents, antialcohol agents, anti-coagulants agents, genetic material, antithrombolytic agents, anticancer agents, anti-Parkinson agents, antiepileptic agents, anti-inflammatory agents, anticonception agents, enzymes agents, cells, growth factors, antiviral agents, antibacterial agents, antifungal agents, hypoglycemic agents, antihistamine agents, chemoattractants, neutraceuticals, antiobesity agents, smoking cessation agents, obstetric agents and antiasmatic agents. 8. The tissue graft of claim 1 further comprising one or more biocompatible polymeric materials. 9. The tissue graft of claim 8 wherein the one or more biocompatible polymeric materials are selected from the group consisting of epoxies, polyesters, acrylics, nylons, silicones, polyanhydride, polyurethane, polycarbonate, poly(tetrafluoroethylene), polycaprolactone, polyethylene oxide, polyethylene glycol, poly(vinyl chloride), polylactic acid, polyglycolic acid, polypropylene oxide, poly(alkylene)glycol, polyoxyethylene, sebacic acid, polyvinyl alcohol, 2-hydroxyethyl methacrylate, polymethyl methacrylate, 1,3-bis(carboxyphenoxy)propane, lipids, phosphatidylcholine, triglycerides, polyhydroxybutyrate, polyhydroxyvalerate, poly(ethylene oxide), poly ortho esters, poly (amino acids), polycynoacrylates, polyphophazenes, polysulfone, polyamine, poly (amido amines), fibrin, graphite, flexible fluoropolymer, isobutyl-based, isopropyl styrene, vinyl pyrrolidone, cellulose acetate dibutyrate, silicone rubber, and copolymers of these. 10. The tissue graft of claim 1 wherein the tissue graft is crosslinked with one or more crosslinking agents. 11. The tissue graft of claim 10 wherein the one or more crosslinking agents are selected from the group consisting of glutaraldehyde, p-Azidobenzolyl Hydazide, N-5-Azido 2-nitrobenzoyloxysuccinimide, N-Succinimidyl 6-[4′azido-2′nitro-phenylamino]hexanoate and 4-[p-Azidosalicylamido] butylamine. 12. The tissue graft of claim 1 wherein the biocompatible protein materials are collagen and elastin. 13. The tissue graft of claim 1, wherein one or more additives in an amount up to 300% based upon the weight of the biocompatible protein material is included. 14. The tissue graft of claim 6 wherein the one or more pharmacologically active agents are included in the amount of 0.001% to 200% based upon the weight of the biocompatible protein material. 15. A method of replacing damaged, diseased or missing tissue comprising: providing a tissue graft comprising one or more biocompatible protein materials, combined with one or more biocompatible solvents and one or more pharmacologically active agents, cells or combinations thereof, wherein the protein material(s), biocompatible solvent(s) and pharmacologically active agent(s), cells or combinations thereof are formed into a cohesive solid body having a solvent content of about 20% to 80% prior to compression and not having the characteristics of cracking, shattering, breaking or being crosslinked so as to inhibit the cohesive solid body from remaining cohesive unto itself when being formed and the cohesive solid body is compressed at a pressure of about 100 psi to 100,000 psi to remove bulk biocompatible solvent and generate additional intermolecular and intramolecular forces between one or more of the protein material(s), solvent(s) and/or active agent(s) to form the tissue graft having a solvent content of about 10% to 60%; and administering the tissue graft to a part of a patient's body that is damaged, diseased or missing, wherein the tissue graft provides a scaffold for enhancing cellular remodeling by host tissue. 16. The method of replacing damaged, diseased or missing tissue of claim 15 wherein the biocompatible solvent is selected from the group consisting of water, dimethyl sulfoxide (DMSO), biocompatible alcohols, biocompatible acids, oils and biocompatible glycols. 17. The method of replacing damaged, diseased or missing tissue of claim 15 wherein the one or more pharmacologically active agents are selected from the group consisting of analgesics, anesthetics, antipsychotic agents, steroids, antisteroids, corticosteroids, antiglacoma agents, antialcohol agents, anti-coagulants agents, genetic material, antithrombolytic agents, anticancer agents, anti-Parkinson agents, antiepileptic agents, anti-inflammatory agents, anticonception agents, enzymes agents, growth factors, antiviral agents, antibacterial agents, antifungal agents, hypoglycemic agents, antihistamine agents, chemoattractants, neutraceuticals, antiobesity agents, smoking cessation agents, obstetric agents, antimicrobial agents, glycosaminoglycans, and antiasmatic agents. 18. The method of replacing damaged, diseased or missing tissue of claim 15, wherein the pharmacologically active agent comprises a second, migration-vulnerable drug delivery device. 19. The method of replacing damaged, diseased or missing tissue of claim 15, wherein the tissue graft further comprises one or more biocompatible polymeric materials. 20. The method of replacing damaged, diseased or missing tissue of claim 18 wherein the one or more biocompatible polymeric materials are selected from the group consisting of epoxies, polyesters, acrylics, nylons, silicones, polyanhydride, polyurethane, polycarbonate, poly(tetrafluoroethylene), polycaprolactone, polyethylene oxide, polyethylene glycol, poly(vinyl chloride), polylactic acid, polyglycolic acid, polypropylene oxide, poly(alkylene)glycol, polyoxyethylene, sebacic acid polymers, polyvinyl alcohol, 2 hydroxyethyl methacrylate polymers, polymethyl methacrylate, 1,3 bis(carboxyphenoxy)propane polymers, lipids, phosphatidylcholine, triglycerides, polyhydroxybutyrate, polyhydroxyvalerate, poly(ethylene oxide), poly ortho esters, poly (amino acids), polycyanoacrylates, polyphophazenes, polysulfone, polyamine, poly (amido amines), fibrin, graphite, flexible fluoropolymer, isobutyl based polymers, isopropyl styrene polymers, vinyl pyrrolidone polymers, cellulose acetate dibutyrate polymers, silicone rubber, and copolymers and combinations of these. 21. The method of replacing damaged, diseased or missing tissue of claim 15 wherein all or a portion of the tissue graft is crosslinked with one or more crosslinking agents. 22. The method of replacing damaged, diseased or missing tissue of claim 21 wherein the one or more crosslinking reagents are selected from the group consisting of glutaraldehyde, p-Azidobenzolyl Hydazide, N-5-Azido 2-nitrobenzoyloxysuccinimide, N-Succinimidyl 6-[4′azido-2′nitro-phenylamino]hexanoate and 4-[p-Azidosalicylamido] butylamine. 23. The method of replacing damaged, diseased or missing tissue of claim 15 wherein the biocompatible protein materials are collagen and elastin. 24. The method of replacing damaged, diseased or missing tissue of claim 15 wherein the tissue graft includes one or more additives in an amount up to 300% based upon the weight of the biocompatible protein material. 25. The method of replacing damaged, diseased or missing tissue of claim 15 wherein the one or more pharmacologically active agents are included in the amount of 0.001% to 200% based upon the weight of the biocompatible protein material. 26. A method of making a tissue graft, comprising the steps of: (a) preparing a coatable composition comprising one or more biocompatible protein materials and one or more biocompatible solvents;(b) forming the coatable composition into a cohesive solid body having a solvent content of about 20% to 80% prior to compression and not having the characteristics of cracking, shattering, breaking or being crosslinked so as to inhibit the cohesive solid body from remaining cohesive unto itself when being formed;(c) compressing the cohesive solid body at a pressure of about 100 psi to 100,000 psi to remove bulk biocompatible solvent; and(d) forming a tissue graft having a solvent content of about 10% to 60% from a compressed cohesive solid body, wherein the tissue graft provides a scaffold for enhancing cellular remodeling by host tissue. 27. The method of making a tissue graft device of claim 26 wherein the biocompatible proteins are selected from the group consisting of elastin, collagen, albumin, keratin, fibronectin, silk, silk fibroin, actin, myosin, fibrinogen, thrombin, aprotinin, antithrombin III, collagen-heparin, collagen-chondroiten and genetically engineered proteins including blocks of peptide sequences comprising groups of amino acids, collagen-heparin and collagen-chondroiten. 28. The method of making a tissue graft of claim 26 wherein the biocompatible solvent is selected from the group consisting of water, dimethyl sulfoxide (DMSO), biocompatible alcohols, biocompatible acids, oils and biocompatible glycols. 29. The method of making a tissue graft of claim 26, wherein the tissue graft further includes one or more pharmacologically active agents, cells or a combination thereof. 30. The method of making a tissue graft of claim 29 wherein the one or more pharmacologically active agents are selected from the group consisting of analgesics, anesthetics, antipsychotic agents, steroids, antisteroids, corticosteroids, antiglacoma agents, antialcohol agents, anti-coagulants agents, genetic material, antithrombolytic agents, anticancer agents, anti Parkinson agents, antiepileptic agents, anti-inflammatory agents, anticonception agents, enzymes agents, growth factors, antiviral agents, antibacterial agents, antifungal agents, hypoglycemic agents, antihistamine agents, chemoattractants, neutraceuticals, antiobesity agents, smoking cessation agents, obstetric agents, antimicrobial agents, glycosaminoglycans, and antiasmatic agents. 31. The method of making a tissue graft of claim 29, wherein the pharmacologically active agent comprises a second, migration-vulnerable drug delivery device. 32. The method of making a tissue graft of claim 26, wherein the tissue graft further comprises one or more biocompatible polymeric materials. 33. The method of making a tissue graft of claim 32 wherein the one or more biocompatible polymeric materials are selected from the group consisting of epoxies, polyesters, acrylics, nylons, silicones, polyanhydride, polyurethane, polycarbonate, poly(tetrafluoroethylene), polycaprolactone, polyethylene oxide, polyethylene glycol, poly(vinyl chloride), polylactic acid, polyglycolic acid, polypropylene oxide, poly(alkylene)glycol, polyoxyethylene, sebacic acid polymers, polyvinyl alcohol, 2 hydroxyethyl methacrylate polymers, polymethyl methacrylate, 1,3 bis(carboxyphenoxy)propane polymers, lipids, phosphatidylcholine, triglycerides, polyhydroxybutyrate, polyhydroxyvalerate, poly(ethylene oxide), poly ortho esters, poly (amino acids), polycyanoacrylates, polyphophazenes, polysulfone, polyamine, poly (amido amines), fibrin, graphite, flexible fluoropolymer, isobutyl based polymers, isopropyl styrene polymers, vinyl pyrrolidone polymers, cellulose acetate dibutyrate polymers, silicone rubber, and copolymers and combinations of these. 34. The method of making a tissue graft of claim 26 further comprising the step of crosslinking all or a portion of the tissue graft with one or more suitable crosslinking agents. 35. The method of making a tissue graft of claim 34 wherein the one or more crosslinking reagents are selected from the group consisting of glutaraldehyde, p-Azidobenzolyl Hydazide, N-5-Azido 2-nitrobenzoyloxysuccinimide, N-Succinimidyl 6-[4′azido-2′nitro-phenylamino]hexanoate and 4-[p-Azidosalicylamido] butylamine. 36. The method of making a tissue graft of claim 26 wherein the biocompatible protein materials are collagen and elastin. 37. The method of making a tissue graft of claim 26 wherein the tissue graft includes one or more additives in an amount up to 300% based upon the weight of the biocompatible protein material. 38. The method of making a tissue graft of claim 29 wherein the one or more pharmacologically active agents are included in the amount of 0.001% to 200% based upon the weight of the biocompatible protein material.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (115)
Harvey Wilson (Sterling GBX) Light Nicholas D. (Doune Perthshire GBX) Haynes Carla A. (Glasgow GBX), Absorbable composite materials for use in the treatment of periodontal disease.
Rel Bernhard (Knigstein/Taunus DEX) Petri Walter (Niedernhausen/Taunus DEX), Base for mucosal and denture adhesive pastes, a process for the preparation thereof, and pastes having this base.
Schiraldi Michael T. (East Brunswick NJ) Perl Martin M. (Brooklyn NY) Rubin Howard (Rockaway NJ), Bioadhesive extruded film for intra-oral drug delivery and process.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Biologically inert, biocompatible-polymer conjugates.
Collombel Christian (Lyon FRX) Damour Odile (Saint Genis Laval FRX) Gagnieu Christian (Lyon FRX) Poinsignon Frederique (Lyon FRX) Echinard Christian (Gemenos FRX) Marichy Jacques (Lyon FRX), Biomaterials with a base of mixtures of collagen, chitosan and glycosaminoglycans, process for preparing them and their.
Brendel Klaus (Tucson AZ) Duhamel Raymond C. (Tucson AZ), Body implants of extracellular matrix and means and methods of making and using such implants.
Drohan William N. ; MacPhee Martin J. ; Miekka Shirley I. ; Singh Manish S. ; Elson Clive,CAX ; Taylor ; Jr. John R., Chitin hydrogels, methods of their production and use.
Kaplan Donald S. (Weston CT) Muth Ross R. (Brookfield CT) Totakura Nagabhushanam (Norwalk CT) Zinner Darren E. (Norwalk CT) Stone Corbett W. (Newtown CT), Compositions, methods and apparatus for inhibiting fogging of endoscope lenses.
Yannas Ioannis V. (Newtown Center MA) Gordon Philip L. (Lexington MA) Huang Chor (Avon Lake OH) Silver Frederick H. (Danville NH) Burke John F. (Belmont MA), Crosslinked collagen-mucopolysaccharide composite materials.
Phipps Joseph B. (Plymouth MN) Howland Warren W. (Champlin MN) Jevne Allan H. (Anoka MN) Holmblad Carolann (Cambridge MN), Device and method for iontophoretic drug delivery.
Amundson Rodney R. (Lindstrom MN) Hull Vincent W. (Ham Lake MN) Dror Michael (Edina MN) Schwartz Robert S. (Rochester MN), Drug delivery balloon catheter with line of weakness.
David B. Masters, Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices.
Hubbell Jeffrey A. (Austin TX) Pathak Chandrashekhar P. (Waltham MA) Sawhney Amarpreet S. (Newton MA) Desai Neil P. (Los Angeles CA) Hill-West Jennifer L. (Austin TX) Hossainy Syed F. A. (Austin TX), Gels for encapsulation of biological materials.
Folkman Judah (Brookline MA) Langer ; Jr. Robert S. (Somerville MA) Hsieh Dean S. T. (Cambridge MA), Magnetically modulated polymeric drug release system.
Wahlig Helmut (Darmstadt DEX) Dingeldain Elvira (Dreieich DEX) Braun Dietrich (Darmstadt-Arheilgen DEX), Medicinally useful, shaped mass of collagen resorbable in the body.
Nagai Tsuneji (Chofu JPX) Machida Yoshiharu (Kawasaki JPX) Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX), Method and preparation for administration to the mucosa of the oral or nasal cavity.
Nagai Tsuneji (Chofu JPX) Machida Yoshiharu (Kawasaki JPX) Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX), Method and preparation for administration to the mucosa of the oral or nasal cavity.
Dinh Thomas Q. (5319 Baker Rd. Minnetonka MN) Tuch Ronald J. (12330 51st Ave. N. Plymouth MN) Dror Michael (6227 Westridge Blvd. Edina MN), Method of making an intraluminal stent.
Yannas Ioannis V. (Newton Center MA) Burke John F. (Belmont MA) Orgill Dennis P. (Cambridge MA) Skrabut Eugene M. (Beverly MA), Method of promoting the regeneration of tissue at a wound.
Orgill Dennis P. (Belmont MA) Butler Charles E. (Brookline MA) Barlow Mark (Boston MA) Ritterbush Scott (Saugus MA) Yannas Ioannis V. (Newton MA) Compton Carolyn C. (Chestnut Hill MA), Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft.
Orgill Dennis P. ; Butler Charles E. ; Barlow Mark ; Ritterbush Scott ; Yannas Ioannis V. ; Compton Carolyn C., Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft.
Khosravi Farhad ; Hogendijk Michael ; Spiridigliozzi John ; Ross Michael R. ; Patel Himanshu, Methods of making and using coiled sheet graft for single and bifurcated lumens.
Kizawa Hidenori (Tokyo JPX) Fujiyama Norimasa (Tokyo JPX) Kobayashi Jitsuo (Kanagawa JPX) Ito Akinori (Niigata JPX), Mucous membrane-adhering film preparation and process for its preparation.
Song Suk-Zu (Moorpark CA) Morawiecki Andrew (Camarillo CA) Pierce Glenn F. (Thousand Oaks CA) Pitt Colin G. (Westlake Village CA), Multi-layered collagen film compositions for delivery of proteins and methods of using same.
Yannas Ioannis V. (Newton Center MA) Burke John F. (Belmont MA) Gordon Philip L. (Lexington MA) Huang Chor (Avon Lake OH), Multilayer membrane useful as synthetic skin.
Casey Donald J. (Ridgefield CT) Huffman Kenneth R. (Stamford CT), Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same.
Hyon Suong-Hyu (Uji JPX) Ikada Yoshita (Uji JPX), Polylactic acid type microspheres containing physiologically active substance and process for preparing the same.
Cha Younsik (Salt Lake City UT) Choi Young Kweon (Salt Lake City UT) Pai Chaul Min (Taejon KRX), Preparation of peptide containing biodegradable microspheres by melt process.
Yannas Ioannis V. (Newton Center MA) Forbes Martin J. (Kirkland CAX), Procedures for preparing composite materials from collagen and glycosaminoglycan.
Samuelson Lynne A. (West Newton MA) Kaplan David L. (Stow MA) Marx Kenneth A. (Francestown NH) Tripathy Sukant K. (Acton MA) Kumar Jayant (Lowell MA), Process of making Langmuir-Blodgett films having photo-electronic properties.
Yannas Ioannis V. (Newton MA) Orgill Dennis P. (Belmont MA) Loree ; II Howard M. (Cambridge MA) Kirk James F. (Cambridge MA) Chang Albert S. P. (Foster City MA) Mikic Borivoje B. (Cambridge MA) Kraru, Prosthesis for promotion of nerve regeneration.
Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX) Yamashita Gentaro (Koganei JPX), Slow-releasing medical preparation to be administered by adhering to a wet mucous surface.
Reiley Mark A ; Scholten Arie ; Talmadge Karen D ; Scribner Robert M, Systems and methods for treating fractured or diseased bone using expandable bodies.
Buysse Steven P. ; Kennedy Jenifer S. ; Lands Michael J. ; Loeffler Donald R. ; Lukianow S. Wade ; Ryan Thomas P., Vascular tissue sealing pressure control and method.
Biegajski James E. (Foster City CA) Venkatraman Subbu S. (Palo Alto CA) Scott Ann M. (Mountain View CA), Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavi.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.